Mitsubishi Tanabe Pharma Corporation

Yuichi Onda

Wataru Sasaki

Fumihiko Akahoshi

Hideki Ushirogochi

Ryo Sakakibara

Minami Yamaguchi

A compound represented by general formula [I] wherein X represents N or the like, Y represents CH or the like; Rrepresents a cycloalkyl group which may be substituted or the like, Rrepresents an alkyl group or the like, Rrepresents an alkyl group which may be substituted or the like, Rrepresents a hydrogen atom or an alkyl group, or a pharmaceutically acceptable salt thereof has an inhibitory activity on aldosterone synthetase, and is useful as a prophylactic and/or therapeutic agent for various diseases or symptoms associated with aldosterone.

Nitrogen-containing aromatic heterocyclic compound

This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein Ris, for example, a group of the following formula (A-1): wherein ring Ais, for example, a cycloalkyl group which may be substituted,and Ris, for example, a monocyclic cycloalkyl group,or a pharmaceutically acceptable salt thereof.

Disubstituted 1, 2, 4-triazine compound

This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein Ris, for example, a group of the following formula (A-1): wherein ring Ais, for example, a cycloalkyl group which may be substituted, and Ris, for example, a monocyclic cycloalkyl group,or a pharmaceutically acceptable salt thereof.

Growing community of inventors

Osaka, Japan

Yuichi Onda